# Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies

> **NCT05827198** · NA · UNKNOWN · sponsor: **Mondelēz International, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Gastrointestinal Tolerance
- Healthy Population

## Interventions

- **OTHER:** Low-sugar candies compared to regular sugar candies

## Key facts

- **NCT ID:** NCT05827198
- **Lead sponsor:** Mondelēz International, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-12
- **Primary completion:** 2023-12-22
- **Final completion:** 2024-01-27
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827198, "Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05827198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*